On the contrary, low expression of genes (BTG2, CD48, CD69, CXCR6, CYBB, IL7R, IL12B, MEP1A, NMUR1, PDE4B, SLAMF1, SLC1A2, SLC11A2, and STAB1) had shorter survival times in lung cancer (Supplementary Figure S2). This evidence concerns the gene SLAMF1 and lung carcinoma.